- Case report
- Open Access
- Open Peer Review
Hysteroscopic management of a heterotopic pregnancy following uterine artery embolization: a case report
© The Author(s). 2016
- Received: 3 February 2016
- Accepted: 20 October 2016
- Published: 15 November 2016
Intra-uterine pregnancy coexisting with cervical pregnancy (heterotopic pregnancy) is a rare condition and its management is challenging because of the massive bleeding associated with cervical pregnancy. Uterine artery embolization followed by hysteroscopic removal of cervical and intra-uterine products of conception can theoretically prevent massive bleeding and provide a direct view during the removal. Hysteroscopic management following uterine artery embolization of heterotopic pregnancy after in vitro fertilization and embryo transfer is rarely reported.
A 33-year-old primigravida, Asian, married, nonsmoker, nonalcoholic woman presented with heavy vaginal bleeding 3 weeks after in vitro fertilization and embryo transfer with a documented history of two embryo implantations in her uterine cavity. Transvaginal ultrasonography revealed a gestational sac of 15 mm × 9 mm × 9 mm with cardiac activity, showing a 3.0-mm-diameter yolk sac in the uterine cavity and a 15 mm × 11 mm × 8 mm gestational sac with cardiac activity, showing a 2.9-mm-diameter yolk sac in the cervical canal. The bilateral uterine artery embolization followed by hysteroscopic removal of both the gestational products was successfully performed after our patient and her family chose to give up the intra-uterine pregnancy due to the risk of heavy bleeding associated with cervical pregnancy.
Uterine artery embolization followed by hysteroscopic removal of cervical and intra-uterine gestational products in the first trimester is safe and feasible, while preserving future fertility.
- Cervical pregnancy
- Intra-uterine pregnancy
- Heterotopic pregnancy
- Surgical management
- Uterine artery embolization
- Case report
Ectopic pregnancy is an abnormal gestation in which the fertilized ovum is implanted outside the uterine cavity and the ampulla region of fallopian tube is the most common site of implantation . In vitro fertilization and embryo transfer (IVF-ET) has been described as one of the major causes for the condition . The incidence of multiple pregnancy has also increased with the increased use of assisted reproductive technology (ART) and it complicates approximately 0.8 % of pregnancies following infertility treatment . Cervical pregnancy is a life-threatening condition accounting for less than 1 % of ectopic gestations ranging between 1:103 and 1:18 × 104 pregnancies . It generally presents with profuse and painless vaginal bleeding, so diagnosis based on ultrasound imaging should be done as early as possible in order to facilitate the management for controlling severe vaginal bleeding [5, 6]. There are several case reports in the literature about the successful usage of methotrexate administration either intra-muscularly or intra-amniotically, ultrasound-guided injection of potassium chloride (KCl) into the cervical gestation sac or the combination of both methotrexate and KCl injections , and uterine artery embolization (UAE) . In any of the cases, close follow-up is mandatory in order to ensure the efficacy of the applied therapeutics and may demand additional interventions such as dilatation and curettage, hysteroscopic resection, and even hysterectomy. Thus there is no consensus regarding the best therapeutic approach for cervical pregnancy. The incidence of heterotopic pregnancy is extremely low, and a review of available literature fails to find a specific protocol for the management of such a condition. It is well established that hysteroscopy can provide a direct view , and uterine artery embolization can prevent heavy uterine bleeding. With this in mind, we have successfully carried out hysteroscopic removal of gestational products of a heterotopic pregnancy following uterine artery embolization. To the best of our knowledge, this is the first case report about such a management for heterotopic pregnancy after IVF-ET.
A 33-year-old primigravida, Asian, married, nonsmoker, nonalcoholic woman presented with a 3-week history of IVF-ET with documented history of two embryo implantations and 3-day history of painless vaginal bleeding to our outpatient department in May, 2015. The bleeding had increased in volume and she had passed an increasing number of clots over 1 day prior to the presentation. She had undergone right adnexectomy for a right ovarian cyst 1 year ago. She had no history of infectious diseases including sexually transmitted diseases. She had no significant family history including any inherited disorders. She belonged to the middle socioeconomic class.
Our patient was doing well after surgery and her β-hCG titer level was normal 4 weeks postoperatively. Our patient’s vaginal bleeding stopped 1 week after the surgery.
With the increased use of ART, there is an increased rate of multiple pregnancies. Among patients with tubal factor infertility, the incidence of IVF ectopic pregnancy varies from 1.8 to 11 % . Among the ectopic pregnancies achieved through assisted reproductive technologies, cervical pregnancy accounts for 3.7 % of IVF-ET .
The management of cervical pregnancy is challenging due to the associated life-threatening complications [12, 13]. The most effective mode of treatment is still controversial, but the patient can be managed either conservatively or radically. Conservative management includes medical or surgical treatments. Medical treatments include intra-amniotic or systemic administration of methotrexate alone or in combination with KCl for intra-amniotic injection . There is, however, the possibility that when using these approaches the products of gestation may not be resolved or evacuated completely and may remain inside the canal for an extended duration, thus necessitating additional interventions.
Surgical procedures include ultrasound-guided aspiration, cervical tamponade, internal iliac artery or uterine artery ligation or embolization, hysteroscopy-guided curettage, and cervical cerclage . The main problem with various conservative treatments is life-threatening hemorrhage which may necessitate hysterectomy as the radical approach. But in our case, the patient and her family did not give consent for continuing the intra-uterine pregnancy. Our patient and her family were afraid of the possible heavy bleeding associated with cervical pregnancy and any side effects to the fetus by the treatment of the cervical pregnancy. That is why they chose to give up the intra-uterine pregnancy. Therefore, uterine artery embolization was performed in order to control vaginal bleeding due to cervical pregnancy, and to preserve her uterus for future fertility. The subsequent hysteroscopic resection of the retained products of conception was performed, confirming that no retained products of conception were left behind inside her uterus and cervical canal . Our patient recovered well after the surgery.
In conclusion, for the population with heterotopic pregnancy in the first trimester and whose future fertility needs to be preserved, hysteroscopic removal of both gestational products following UAE is an ideal alternative management because it can prevent massive uterine bleeding, and hysteroscopy can provide a direct view for removal of the retained gestational products after vacuum suction.
Availability of data and materials
XS diagnosed this case and JS drafted the manuscript. DX, XLD, MX, and XS revised the manuscript. JS, XY, and KY carried out the acquisition of data and participated in the literature search. DX supervised this manuscript. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Ethics approval and consent to participate
This study was approved by the Institutional Review Board (IRB) of the Third Xiangya Hospital, Central South University and the reference number is 2016-S239.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Shaw JL, Diamandis EP, Horne AW, Barnhart K, Bourne T, Messinis IE. Ectopic pregnancy. Clin Chem. 2012;58(9):1278–85.View ArticlePubMedGoogle Scholar
- Chang HJ, Suh CS. Ectopic pregnancy after assisted reproductive technology: what are the risk factors? Curr Opin Obstet Gynecol. 2010;22(3):202–7.View ArticlePubMedGoogle Scholar
- Wang LL, Chen X, Ye DS, Liu YD, He YX, Guo W, et al. Misdiagnosis and delayed diagnosis for ectopic and heterotopic pregnancies after in vitro fertilization and embryo transfer. J Huazhong Univ Sci Technolog Med Sci. 2014;34:103–7.View ArticlePubMedGoogle Scholar
- Yitzhak M, Orvieto R, Nitke S, Neuman-Levin M, Ben-Rafael Z, Schoenfeld A. Cervical pregnancy--a conservative stepwise approach. Hum Reprod. 1999;14:847–9.View ArticlePubMedGoogle Scholar
- Vela G, Tulandi T. Cervical pregnancy: the importance of early diagnosis and treatment. J Minim Invasive Gynecol. 2007;14(4):481–4.View ArticlePubMedGoogle Scholar
- Sijanović S, Vidosavljević D, Topolovec Z, Milostić-Srb A, Mrčela M. Management of cervical ectopic pregnancy after unsuccessful methotrexate treatment. Iran J Reprod Med. 2014;12(4):285–8.PubMedPubMed CentralGoogle Scholar
- Júnior JE, Musiello RB, Araujo Júnior E, Souza E, Fava JL, Guerzet EA, Camano L. Conservative management of cervical pregnancy with embryonic heart activity by ultrasound-guided local injection: an eight case series. J Matern Fetal Neonatal Med. 2014;27(13):1378–81.View ArticlePubMedGoogle Scholar
- Headley A. Management of cervical ectopic pregnancy with uterine artery embolization: a case report. J Reprod Med. 2014;59(7-8):425–8.PubMedGoogle Scholar
- Ben-Ami I, Melcer Y, Smorgick N, Schneider D, Pansky M, Halperin R. A comparison of reproductive outcomes following hysteroscopic management versus dilatation and curettage of retained products of conception. Int J Gynaecol Obstet. 2014;127(1):86–9.View ArticlePubMedGoogle Scholar
- Gunby J, Bissonnette F, Librach C, Cowan L, IVF Directors Group of the Canadian Fertility and Andrology Society. Assisted reproductive technologies (ART) in Canada: 2004 results from the Canadian ART Register. Fertil Steril. 2008;89(5):1123–32.View ArticlePubMedGoogle Scholar
- Karande VC, Flood JT, Heard N, et al. Analysis of ectopic pregnancies resulting from in-vitro fertilization and embryo transfer. Hum Reprod. 1991;6(3):446–9.View ArticlePubMedGoogle Scholar
- Ushakov FB, Elchalal U, Aceman PJ, Schenker JG. Cervical pregnancy: past and future. Obstet Gynecol Surv. 1997;52(1):45–59.View ArticlePubMedGoogle Scholar
- Monteagudo A, Minior VK, Stephenson C, Monda S, Timor-Tritsch IE. Non-surgical management of live ectopic pregnancy with ultrasound-guided local injection: a case series. Ultrasound Obstet Gynecol. 2005;25(3):282–8.View ArticlePubMedGoogle Scholar
- Pereira N, Grias I, Foster SE, Della Badia CR. Acute hemorrhage related to a residual cervical pregnancy: management with curettage, tamponade, and cerclage. J Minim Invasive Gynecol. 2013;20(6):907–11.View ArticlePubMedGoogle Scholar